Oric Pharmaceuticals Stock Scores RS Rating Upgrade

Group 1 - Oric Pharmaceuticals (ORIC) stock had its Relative Strength (RS) Rating upgraded from 80 to 83, indicating improved performance compared to other stocks over the past 52 weeks [1] - Dianthus Therapeutics stock saw a significant increase of 47% in four weeks and received an RS Rating upgrade [4] - Google stock reached a record high and was included in top stock lists, highlighting its strong market performance [4] Group 2 - PTC Therapeutics stock's RS Rating improved to 77, reflecting a positive trend in its stock performance [4] - Stocks to watch include Oric Pharmaceuticals, which saw its RS Rating jump to 82, indicating strong market interest [4] - The market experienced a sour note at the end of August, with companies like Expedia, DR Horton, and Argenx being in focus for investors [4]